sel
Showing 1 - 6 of 6
Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) Trial in New Zealand, United States (SEL, FIR,
Completed
- Nonalcoholic Steatohepatitis (NASH)
- Nonalcoholic Fatty Liver Disease (NAFLD)
- SEL
- +4 more
-
Chandler, Arizona
- +12 more
Mar 7, 2022
Nonalcoholic Steatohepatitis Trial in Worldwide (SEL, FIR, CILO)
Completed
- Nonalcoholic Steatohepatitis
- SEL
- +5 more
-
Chandler, Arizona
- +100 more
Dec 1, 2020
Nonalcoholic Steatohepatitis Trial in Worldwide (SEL, Placebo to match SEL 6 mg, Placebo to match SEL 18 mg)
Terminated
- Nonalcoholic Steatohepatitis
- SEL
- +2 more
-
Chandler, Arizona
- +297 more
Jun 10, 2020
Nonalcoholic Steatohepatitis Trial in Worldwide (SEL, Placebo to match SEL 6 mg, Placebo to match SEL 18 mg)
Terminated
- Nonalcoholic Steatohepatitis
- SEL
- +2 more
-
Chandler, Arizona
- +282 more
Apr 24, 2020
Non-Alcoholic Steatohepatitis (NASH) Trial in Canada, United States (SEL, SIM)
Completed
- Non-Alcoholic Steatohepatitis (NASH)
- SEL
- SIM
-
Palo Alto, California
- +27 more
May 31, 2019